VAERS reports by lot

GSK DTaP/Tdap lot 7KM94: VAERS reports

63 VAERS reports list lot 7KM94 as a GSK DTaP/Tdap vaccine, received between 2022-04-04 and 2024-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
63
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2261%
Allergic / Anaphylactic411%
General / Systemic (non-local)38%
Neurological26%
Musculoskeletal26%
Gastrointestinal13%
Dermatological (non-injection-site)13%
Psychiatric / Neuropsychiatric13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas8
California4
Colorado4
Indiana3
Illinois3
Massachusetts2
Pennsylvania2
Nevada2
Ohio2
Missouri2
Minnesota2
Michigan2

Reports by month received

2022-044
2022-055
2022-067
2022-076
2022-084
2022-093
2022-102
2022-123
2023-021
2023-041
2023-051
2023-0614
2023-078
2023-081
2023-091
2023-111
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.